by Sonja Köhler | Jul 19, 2021
Status: | Marker: KRAS Title A phase I open-label dose escalation trial of BI 1701963 as monotherapy and in combination with trametinib in patients with KRAS mutated advanced or metastatic solid tumours Study Number Indication Solid Tumor with previously-identified...
by Sonja Köhler | Aug 17, 2020
Status: | Marker: BRAF, KRAS Title Study Number Indication Primary Objective In- and exclusion Criteria Study Design Responsibilities Trial Centre Principal investigator Letzte...
